Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Effects of Qigong on quality of life, fatigue, stress, neuropathy, and sexual function in women with metastatic breast cancer: a feasibility study
Oh B, Butow P, Boyle F, Beale P, Costa DSJ, Pavlakis N, Bell D, Davis E, Choi SM, Lee MS, Rosenthal D, Clark S
International Journal of Physical Medicine & Rehabilitation 2014 Jul 29;2(217):Epub
clinical trial
2/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: No; Baseline comparability: No; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: No. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

BACKGROUND: Women with metastatic breast cancer (MBC) suffer from psychological and physiological symptoms and side effects of therapy. When the treatment is non-curative, quality of life (QOL) is a major issue. This study aimed to examine the feasibility, safety, and effects of Medical Qigong (MQ: integration of gentle exercise and meditation) in improving QOL in women with MBC. METHOD: Women with MBC were randomized to a MQ group (n = 14) or meditation control group (n = 13). QOL, fatigue, stress, neuropathy symptoms and sexual function were measured by the Functional Assessment of Cancer Therapy Breast (FACT-B), Functional Assessment of Cancer Therapy-fatigue (FACT-F), Perceived Stress Scale (PSS), neurotoxicity subscale of the FACT/GOG-NTX, and Sexual Functioning Questionnaire (SFQ) subscales at pre-intervention and weeks 5 and 10. RESULTS: No serious adverse events were reported during or after MQ intervention. Sixty three percent of participants completed the study (MQ intervention (n = 9) and meditation control (n = 8)). There were no significant differences in overall QOL (p = 0.84), fatigue (p = 0.71), perceived stress level (p= 0.52), sexual satisfaction (p = 0.55), sexual activities (p = 0.95) and sexual relationship (p = 0.79) between the groups, although difference in neuropathic symptoms (p = 0.014) were significant. CONCLUSIONS: A MQ trial in women with MBC is feasible and safe. MQ may have the potential to relieve symptoms experienced by women with MBC and prevent deterioration of neuropathy. A larger study with adequate power to confirm these results and detect clinically relevant effects is needed.

Full text (sometimes free) may be available at these link(s):      help